| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |